Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01567930
Title Temsirolimus as Second-line Therapy in HCC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Tennessee Cancer Institute
Age Groups: adult
Covered Countries USA

No variant requirements are available.